Antidepressants taken by one in 10 European adults

By Admin
Share
Ten percent of all middle-aged people in Europe took antidepressants in 2010, according to a new survey. The highest rate of antidepressant dependence...

Ten percent of all middle-aged people in Europe took antidepressants in 2010, according to a new survey.

The highest rate of antidepressant dependence was found to be in Portugal, which was closely followed by the UK and Lithuania.

Rates of antidepressant usage in the latter two countries were described by researchers as higher than normal and overall they said the results were concerning.

Findings also revealed that incidences of antidepressant usage were more common in women who were unemployed and divorced or separated.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

The study was carried out by the University of Warwick who worked in partnership with IZA Institute in Bonn and over 30,000 European adults were the subjects of the study.

Andrew Oswald from the University of Warwick said in a media interview: “As we live in the richest and safest era in the history of humans, perhaps we are going to have to ask ourselves why one in ten of Europe’s middle-aged citizens need a pill to cope with life.”

“That is an awful lot of people relying on chemical happiness.”

The researchers believe that the results mirror the theory that people experience a ‘U-turn’ in regards to their happiness and well being.

The theory states that at the beginning and end of their lives people are fairly contented and settled but during their middle years they can become stressed at home and work which could lead to a mid-life crisis. 

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma